Stimulation of non-specific immunity, gene expression, and disease resistance in Nile Tilapia, (Linnaeus, 1758), by the methanolic extract of the marine macroalga, .

Aim: The objective of the present study was to test the immunostimulating potential of marine macroalga, , in terms of non-specific immune responses, gene expression, and disease resistance of Nile tilapia, (Linnaeus, 1758).

Materials And Methods: was injected intraperitoneally with three different doses of methanol extract of (CSME) (2 mg/kg, 20 mg/kg, or 200 mg/kg body weight), or MacroGard™ (commercial immunostimulant, positive control, and 20 mg/kg body weight), or distilled water (untreated control). In one set of fish, 5 days post-injection, serum lysozyme, myeloperoxidase, and antiprotease activities were assayed. 24 h after injection, gene expression was analyzed in a separate set of fish. To another set of fish, 1 week post-administration of the products, fish were challenged with lethal dose 50 (LD) dose of a live virulent pathogen, and subsequent resistance to it was noted in terms of cumulative percent mortality.

Results: CSME increased serum lysozyme, myeloperoxidase, and antiprotease activities. There was an increase in the expression of lysozyme gene in the spleen of treated fish. Mid dose of CSME caused the minimum mortality of 10% (consequent relative percentage survival = 73) which is comparable to that of the positive control.

Conclusion: CSME is considered to have the potential to be developed into an immunostimulant for finfish aquaculture.